These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2275242)

  • 1. Validity of information received from pharmaceutical companies.
    Wilson DE; Crabbe SJ
    DICP; 1990 Nov; 24(11):1117. PubMed ID: 2275242
    [No Abstract]   [Full Text] [Related]  

  • 2. Responses from pharmaceutical companies to doctors' requests for more drug information in Pakistan: postal survey.
    Hafeez A; Mirza Z
    BMJ; 1999 Aug; 319(7209):547. PubMed ID: 10463894
    [No Abstract]   [Full Text] [Related]  

  • 3. Information responsibilities of generic drug companies.
    Cramer R
    Am J Hosp Pharm; 1986 Jul; 43(7):1674, 1679. PubMed ID: 3752098
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality of drug information service provided by pharmaceutical manufacturers.
    Doyal LE
    Am J Hosp Pharm; 1990 May; 47(5):1014. PubMed ID: 2337090
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical sales representatives and patient safety.
    Light DW
    J Gen Intern Med; 2013 Nov; 28(11):1394. PubMed ID: 23884603
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical sales representatives and patient safety.
    Mintzes B; Lexchin J; Wilkes MS; Beaulieu MD; Reynolds E; Sutherland J; Durrieu G
    J Gen Intern Med; 2013 Nov; 28(11):1395. PubMed ID: 23897129
    [No Abstract]   [Full Text] [Related]  

  • 7. Misleading advertising of PI-based drug information?
    Bandler LG
    Med J Aust; 2008 Aug; 189(3):181. PubMed ID: 18673116
    [No Abstract]   [Full Text] [Related]  

  • 8. Information from drug companies and opinion leaders.
    Liberati A; Magrini N
    BMJ; 2003 May; 326(7400):1156-7. PubMed ID: 12775588
    [No Abstract]   [Full Text] [Related]  

  • 9. Secrecy and the health protection branch.
    Lexchin J
    CMAJ; 1998 Sep; 159(5):481-3. PubMed ID: 9757171
    [No Abstract]   [Full Text] [Related]  

  • 10. Responsiveness to physicians' requests for information concerning drug interactions: a comparison of brand and generic companies.
    Thomas M; Lexchin J
    Soc Sci Med; 1990; 31(2):153-7. PubMed ID: 2389150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating manufacturer-affiliated communication in the information age.
    Schulman KA; Abernethy DR; Rathore SS; Woosley RL
    Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
    [No Abstract]   [Full Text] [Related]  

  • 12. From the editor--drug companies under investigation.
    Thomas SP
    Issues Ment Health Nurs; 2004 Dec; 25(8):751-2. PubMed ID: 15545240
    [No Abstract]   [Full Text] [Related]  

  • 13. Timeliness of receipt of manufacturers' new product information.
    Murdoch LA; Lum L
    Can J Hosp Pharm; 1991 Oct; 44(5):235-8. PubMed ID: 10115576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?
    Cardarelli R; Licciardone JC; Taylor LG
    BMC Fam Pract; 2006 Mar; 7():13. PubMed ID: 16515686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing exposure of hospital staff to incorrect drug information.
    Jankovic SM; Radonjic V; Cupara S; Stefanovic S
    Int J Clin Pharmacol Ther; 2008 Dec; 46(12):652-3. PubMed ID: 19049699
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug detailing in the hospital: background for policy development.
    Chan J; Einarson T
    Can J Hosp Pharm; 1991 Jun; 44(3):161-6. PubMed ID: 10112744
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the innovation-based pharmaceutical industry in international drug information communication.
    Hoff LC
    Drug Inf J; 1983; 17(4):271-6. PubMed ID: 10265100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the quality of drug detailing.
    Molloy W; Strang D; Guyatt G; Lexchin J; Bédard M; Dubois S; Russo R
    J Clin Epidemiol; 2002 Aug; 55(8):825-32. PubMed ID: 12384198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A standard of knowledge for pharmaceutical sales representatives.
    Bootman JL
    Manag Care Interface; 2006 Oct; 19(10):13. PubMed ID: 17117593
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.